ECM Therapeutics, Inc.

CIK 1743104 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for ECM Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Oct 10, 2025D/A0001743104-25-000002
May 30, 2024D/A0001743104-24-000001
Jun 9, 2023D/A0001743104-23-000001
Sep 14, 2022D/A0001743104-22-000001
Jul 30, 2021D/A0001743104-21-000001
Sep 18, 2019D/A0001743104-19-000003
Jun 18, 2019D/A0001743104-19-000001
Jun 8, 2018D0001743104-18-000002